The RNA binding domain of Jerky consists of tandemly arranged helix-turn-helix/homeodomain-like motifs and binds specific sets of mRNAs

Molecular and Cellular Biology

Volumn 23, Issue 12, 2003, Pages 4083-4093

  Liu, Wencheng ^a   Seto, Jeremy ^b   Sibille, Etienne ^c   Toth, Miklos ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b Weill Cornell Graduate School of Biomedical Sciences   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSKELETON PROTEIN; DOUBLE STRANDED DNA; HELIX LOOP HELIX PROTEIN; HOMEODOMAIN PROTEIN; HYBRID PROTEIN; JERKY PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CENTROMERE; CONTROLLED STUDY; DNA BINDING MOTIF; EPILEPTOGENESIS; GENE DELETION; GENE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN RNA BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RIBOSOME; SEQUENCE HOMOLOGY; TEMPORAL LOBE EPILEPSY; UNINDEXED SEQUENCE;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; CELL LINE; DISEASE MODELS, ANIMAL; DNA; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; GLUTATHIONE TRANSFERASE; HUMANS; KINETICS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; NERVE TISSUE PROTEINS; NEURONS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SEQUENCE HOMOLOGY, AMINO ACID; TRANSFECTION;

ANIMALIA; MAMMALIA;

EID: 0038656462     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.23.12.4083-4093.2003     Document Type: Article

References (56)

1. Bandziulis, R. J., M. S. Swanson, and G. Dreyfuss. 1989. RNA-binding proteins as developmental regulators. Genes Dev. 3:431-437.
2. Banerjee-Basu, S., and A. D. Baxevanis. 2001. Molecular evolution of the homeodomain family of transcription factors. Nucleic Acids Res. 29:3258-3269.
3. Berkovic, S. F., M. L. Kennerson, R. A. Howell, I. E. Scheffer, P. A. Hwang, and G. A. Nicholson. 1994. Phenotypic expression of benign familial neonatal convulsions linked to chromosome 20. Arch. Neurol. 51:1125-1128.
4. Berkovic, S. F., A. McIntosh, R. A. Howell, A. Mitchell, L. J. Sheffield, and J. L. Hopper. 1996. Familial temporal lobe epilepsy: a common disorder identified in twins. Ann. Neurol. 40:227-235.
5. Brown, V., P. Jin, S. Ceman, J. C. Darnell, W. T. O'Donnell, S. A. Tenenbaum, X. Jin, Y. Feng, K. D. Wilkinson, J. D. Keene, et al.. 2001. Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487.
6. Burz, D. S., R. Rivera-Pomar, H. Jackie, and S. D. Hanes. 1998. Cooperative DNA-binding by Bicoid provides a mechanism for threshold-dependent gene activation in the Drosophila embryo. EMBO J. 17:5998-6009.
7. Cendes, F., I. Lopes-Cendes, E. Andermann, and F. Andermann. 1998. Familial temporal lobe epilepsy: a clinically heterogeneous syndrome. Neurology 50:554-557.
8. Chen, L., and M. Toth. 2001. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience 103:1043-1050.
9. Donovan, G. P., C. Harden, J. Gal, L. Ho, E. Sibille, R. Trifiletti, L. J. Gudas, and M. Toth. 1997. Sensitivity to jerky gene dosage underlies epileptic seizures in mice. J. Neurosci. 17:4562-4569.
10. Driever, W., and C. Nusslein-Volhard. 1989. The bicoid protein is a positive regulator of hunchback transcription in the early Drosophila embryo. Nature 337:138-143.
11. Dubnau, J., and G. Struhl. 1996. RNA recognition and translational regulation by a homeodomain protein. Nature 379:694-699.
12. Eberhart, D. E., H. E. Malter, Y. Feng, and S. T. Warren. 1996. The fragile X mental retardation protein is a ribonucleoprotein containing both nuclear localization and nuclear export signals. Hum. Mol. Genet. 5:1083-1091.
13. Gambardella, A., D. Messina, E. Le Piane, R. L. Oliveri, G. Annesi, M. Zappia, E. Andermann, A. Quattrone, and U. Aguglia. 2000. Familial temporal lobe epilepsy autosomal dominant inheritance in a large pedigree from southern Italy. Epilepsy Res. 38:127-132.
14. Gao, Q., and R. Finkelstein. 1998. Targeting gene expression to the head: the Drosophila orthodenticle gene is a direct target of the Bicoid morphogen. Dev. Suppl. 125:4185-4193.
15. Guerrini, R., C. Dravet, A. R. Ferrari, A. Battaglia, M. G. Mattei, P. Salvadori, P. Genton, and P. Pfanner. 1993. The evolution of epilepsy in the most common genetic forms with mental retardation (Down's syndrome and the fragile X syndrome). Pediatr. Med. Chiragu 15(Suppl. 1):19-22.
16. Hayes, J. D., and R. C. Strange. 2000. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology 61:154-166.
17. 2 in vitro. Brain Res. 671:181-186.
18. Ikeda, A., T. Kunieda, S. Miyamoto, H. Fukuyama, and H. Shibasaki. 2000. Autosomal dominant temporal lobe epilepsy in a Japanese family. J. Neurol. Sci. 176:162-165.
19. Iwahara, J., T. Kigawa, K. Kitagawa, H. Masumoto, T. Okazaki, and S. Yokoyama. 1998. A helix-turn-helix structure unit in human centromere protein B (CENP-B). EMBO J. 17:827-837.
20. Kenan, D. J., C. C. Query, and J. D. Keene. 1991. RNA recognition: towards identifying determinants of specificity. Trends Biochem. Sci. 16:214-220.
21. Khandjian, E. W., F. Corbin, S. Woerly, and F. Rousseau. 1996. The fragile X mental retardation protein is associated with ribosomes. Nat. Genet. 12:91-93.
22. Kiledjian, M., and G. Dreyfuss. 1992. Primary structure and binding activity of the hnRNP U protein: binding RNA through RGG box. EMBO J. 11:2655-2664.
23. Laggerbauer, B., D. Ostareck, E. M. Keidel, A. Ostareck-Lederer, and U. Fischer. 2001. Evidence that fragile X mental retardation protein is a negative regulator of translation. Hum. Mol. Genet. 10:329-338.
24. Lazinski, D., E. Grzadzielska, and A. Das. 1989. Sequence-specific recognition of RNA hairpins by bacteriophage antiterminators requires a conserved arginine-rich motif. Cell 59:207-218.
25. Li, Z., Y. Zhang, L. Ku, K. D. Wilkinson, S. T. Warren, and Y. Feng. 2001. The fragile X mental retardation protein inhibits translation via interacting with mRNA. Nucleic Acids Res. 29:2276-2283.
26. Liu, W., J. Seto, G. Donovan, and M. Toth. 2002. Jerky, a protein deficient in a mouse epilepsy model, is associated with translationally inactive mRNA in neurons. J. Neurosci. 22:176-182.
27. Matz, P. G., A. Lewen, and P. H. Chan. 2001. Neuronal, but not microglial, accumulation of extravasated serum proteins after intracerebral hemolysate exposure is accompanied by cytochrome c release and DNA fragmentation. J. Cereb. Blood Flow Metab. 21:921-928.
28. Meyuhas, O., D. Avni, and S. Shama. 1996. Translational control of ribosomal protein mRNAs in eukaryotes, p. 363-388. In J. W. B. Hershey, M. B. Mathews, and N. Sonenberg, (ed.), Translational control. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
29. Moore, T., S. Hecquet, A. McLellann, D. Ville, D. Grid, F. Picard, B. Moulard, P. Asherson, A. J. Makoff, D. McCormick, et al. 2001. Polymorphism analysis of JRK/JH8, the human homologue of mouse jerky, and description of a rare mutation in a case of CAE evolving to JME. Epilepsy Res. 46:157-167.
30. Morita-Fujimura, Y., M. Fujimura, M. Kawase, S. F. Chen, and P. H. Chan. 1999. Release of mitochondrial cytochrome c and DNA fragmentation after cold injury-induced brain trauma in mice: possible role in neuronal apoptosis. Neurosci. Lett. 267:201-205.
31. Musumeci, S. A., P. Bosco, G. Calabrese, C. Bakker, G. B. De Sarro, M. Elia, R. Ferri, and B. A. Oostra. 2000. Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41:19-23.
32. Musumeci, S. A., R. J. Hagerman, R. Ferri, P. Bosco, B. Dalla Bernardina, C. A. Tassinari, G. B. De Sarro, and M. Elia. 1999. Epilepsy and EEG findings in males with fragile X syndrome. Epilepsia 40:1092-1099.
33. Niessing, D., W. Driever, F. Sprenger, H. Taubert, H. Jackie, and R. Rivera-Pomar. 2000. Homeodomain position 54 specifies transcriptional versus translational control by Bicoid. Mol. Cell 5:395-401.
34. Olanow, C. W. 1993. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:439-444.
35. Oltvai, Z. N., C. L. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609-619.
36. Picard, F., S. Baulac, P. Kahane, E. Hirsch, R. Sebastianelli, P. Thomas, F. Vigevano, P. Genton, R. Guerrini, C. A. Gericke, et al. 2000. Dominant partial epilepsies. A clinical, electrophysiological and genetic study of 19 European families. Brain 123:1247-1262.
37. Poza, J. J., A. Saenz, A. Martinez-Gil, N. Cheron, A. M. Cobo, M. Urtasun, J. F. Marti-Masso, D. Grid, J. S. Beckmann, J. F. Prud'homme, and A. Lopez de Munain. 1999. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann. Neurol. 45:182-188.
38. Qiu, J., M. J. Whalen, P. Lowenstein, G. Fiskum, B. Fahy, R. Darwish, B. Aarabi, J. Yuan, and M. A. Moskowitz. 2002. Upregulation of the Fas receptor death-inducing signaling complex after traumatic brain injury in mice and humans. J. Neurosci. 22:3504-3511.
39. Rabilloud, T., M. Heller, F. Gasnier, S. Luche, C. Rey, R. Aebersold, M. Benahmed, P. Louisot, and J. Lunardi. 2002. Proteomics analysis of cellular response to oxidative stress. Evidence for in vivo overoxidation of peroxiredoxins at their active site. J. Biol. Chem. 277:19396-19401.
40. Rivera-Pomar, R., D. Niessing, U. Schmidt-Ott, W. J. Gehring, and H. Jackie. 1996. RNA binding and translational suppression by bicoid. Nature 379:746-749.
41. Rosch, P., and D. Willbold. 1996. Is EIAV Tat protein a homeodomain? Science 272:1672.
42. Saenz, A., J. Galan, C. Caloustian, F. Lorenzo, C. Marquez, N. Rodriguez, M. D. Jimenez, J. J. Poza, A. M. Cobo, D. Grid, et al. 1999. Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene. Arch. Neurol. 56:1004-1009.
43. Samali, A., and S. Orrenius. 1998. Heat shock proteins: regulators of stress response and apoptosis. Cell Stress Chaperones 3:228-236.
44. Schaeffer, C., B. Bardoni, J. L. Mandel, B. Ehresmann, C. Ehresmann, and H. Moine. 2001. The fragile X mental retardation protein binds specifically to its mRNA via a purine quartet motif. EMBO J. 20:4803-4813.
45. Simonian, N. A., and J. T. Coyle. 1996. Oxidative stress in neurodegenerative diseases. Annu. Rev. Pharmacol. Toxicol. 36:83-106.
46. Siomi, H., M. C. Siomi, R. L. Nussbaum, and G. Dreyfuss. 1993. The protein product of the fragile X gene, FMR1, has characteristics of an RNA-binding protein. Cell 74:291-298.
47. Slee, E. A., M. T. Harte, R. M. Kluck, B. B. Wolf, C. A. Casiano, D. D. Newmeyer, H. G. Wang, J. C. Reed, D. W. Nicholson, E. S. Alnemri, et al. 1999. Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144:281-292.
48. Struhl, G., K. Struhl, and P. M. Macdonald. 1989. The gradient morphogen bicoid is a concentration-dependent transcriptional activator. Cell 57:1259-1273.
49. Sugawara, T., M. Fujimura, Y. Morita-Fujimura, M. Kawase, and P. H. Chan. 1999. Mitochondrial release of cytochrome c corresponds to the selective vulnerability of hippocampal CA1 neurons in rats after transient global cerebral ischemia. J. Neurosci. 19:RC39.
50. Swanson, M. S., T. Y. Nakagawa, K. LeVan, and G. Dreyfuss. 1987. Primary structure of human nuclear ribonucleoprotein particle C proteins: conservation of sequence and domain structures in heterogeneous nuclear RNA, mRNA, and pre-rRNA-binding proteins. Mol. Cell. Biol. 7:1731-1739.
51. Tanaka, Y., O. Nureki, H. Kurumizaka, S. Fukai, S. Kawaguchi, M. Ikuta, J. Iwahara, T. Okazaki, and S. Yokoyama. 2001. Crystal structure of the CENP-B protein-DNA complex: the DNA-binding domains of CENP-B induce kinks in the CENP-B box DNA. EMBO J. 20:6612-6618.
52. Tenenbaum, S. A., C. C. Carson, P. J. Lager, J. D. Keene. 2000. Identifying mRNA subsets in messenger ribonucleoprotein complexes by using cDNA arrays. Proc. Natl. Acad. Sci. USA 97:14085-14090.
53. Toth, M. 2001. RNA binding proteins and epilepsy. Gene Function Dis. 2:95-98.
54. Toth, M., J. Grimsby, G. Buzsaki, and G. P. Donovan. 1995. Epileptic seizures caused by inactivation of a novel gene, jerky, related to centromere binding protein-B in transgenic mice. Nat. Genet. 11:71-75.
55. Wisniewski, K. E., J. H. French, S. Fernando, W. T. Brown, E. C. Jenkins, E. Friedman, A. L. Hill, and C. M. Miezejeski. 1985. Fragile X syndrome: associated neurological abnormalities and developmental disabilities. Ann. Neurol. 18:665-669.
56. Wisniewski, K. E., S. M. Segan, C. M. Miezejeski, E. A. Sersen, and R. D. Rudelli. 1991. The Fra(X) syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am. J. Med. Genet. 38:476-480.